These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25 related articles for article (PubMed ID: 20984885)
1. Highlights on U.S. FDA-approved fluorinated drugs over the past five years (2018-2022). Ali S; Zhou J Eur J Med Chem; 2023 Aug; 256():115476. PubMed ID: 37207534 [TBL] [Abstract][Full Text] [Related]
2. Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations. Gilad Y; Gellerman G; Lonard DM; O'Malley BW Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33562300 [TBL] [Abstract][Full Text] [Related]
3. Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy. Anteby R; Kemeny NE; Kingham TP; D'Angelica MI; Wei AC; Balachandran VP; Drebin JA; Brennan MF; Blumgart LH; Jarnagin WR J Am Coll Surg; 2021 Mar; 232(3):332-338. PubMed ID: 33387624 [No Abstract] [Full Text] [Related]
4. Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium. Falzone L; Salomone S; Libra M Front Pharmacol; 2018; 9():1300. PubMed ID: 30483135 [TBL] [Abstract][Full Text] [Related]
5. Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine. Coyle KM; Boudreau JE; Marcato P Biomed Res Int; 2017; 2017():9620870. PubMed ID: 28685150 [TBL] [Abstract][Full Text] [Related]
6. Molecular chess? Hallmarks of anti-cancer drug resistance. Cree IA; Charlton P BMC Cancer; 2017 Jan; 17(1):10. PubMed ID: 28056859 [TBL] [Abstract][Full Text] [Related]
7. Impact of temozolomide on gonadal function in patients with primary malignant brain tumors. Strowd RE; Blackwood R; Brown M; Harmon M; Lovato J; Yalcinkaya T; Lesser G J Oncol Pharm Pract; 2013 Dec; 19(4):321-7. PubMed ID: 23292971 [TBL] [Abstract][Full Text] [Related]
8. Observations of unprecedented remissions following novel treatment for acute leukemia in children in 1948. Spain PD; Kadan-Lottick N J R Soc Med; 2012 Apr; 105(4):177-81. PubMed ID: 22532657 [No Abstract] [Full Text] [Related]
9. O. Harold Warwick: Canada's first medical oncologist. Cowan DH Curr Oncol; 2011 Jun; 18(3):e117-20. PubMed ID: 21655149 [TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of cyclophosphamide. Moore MJ Clin Pharmacokinet; 1991 Mar; 20(3):194-208. PubMed ID: 2025981 [TBL] [Abstract][Full Text] [Related]
12. A quantitative study of the hemopoietic organs of albino rats following intravenous injection of mustard and nitrogen mustards. KINDRED JE Anat Rec; 1946 Mar; 94():474. PubMed ID: 21020600 [No Abstract] [Full Text] [Related]
13. Biochemical research on chemical warfare agents. DIXON M; NEEDHAM DM Nature; 1946 Sep; 158():432-8. PubMed ID: 20999100 [No Abstract] [Full Text] [Related]
14. [EFFECT OF NITROGEN MUSTARD GAS POISONING ON SERUM PROTEINS]. DAVID G; FIAM B Radiobiol Radiother (Berl); 1964; 5():699-702. PubMed ID: 14320361 [No Abstract] [Full Text] [Related]
15. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders. GOODMAN LS; WINTROBE MM J Am Med Assoc; 1946 Sep; 132():126-32. PubMed ID: 20997191 [No Abstract] [Full Text] [Related]
16. Nitrogen mustards in the treatment of neoplastic disease; official statement. RHOADS CP J Am Med Assoc; 1946 Jun; 131():656-8. PubMed ID: 20984885 [No Abstract] [Full Text] [Related]
17. Nitrogen mustard therapy; studies on the effect of methyl-bis (beta-chloroethyl) amine hydrochloride on neoplastic diseases and allied disorders of the hemopoietic system. JACOBSON LO; SPURR CL J Am Med Assoc; 1946 Oct; 132():263-71. PubMed ID: 20997209 [No Abstract] [Full Text] [Related]